Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
9271893 | Osteoarthritis and Cartilage | 2005 | 9 Pages |
Abstract
Growing preclinical and clinical evidence supports the notion that, in addition to relieving the symptoms of OA, HAs also modify the structure of the diseased joint and the rate of OA disease progression, at least early in the evolution of the disease process.
Related Topics
Health Sciences
Medicine and Dentistry
Immunology, Allergology and Rheumatology
Authors
V.M. M.D., J.A. M.D.,